New mammogram technique could spare thousands from needless breast biopsies
NCT ID NCT05206331
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study tests whether contrast-enhanced mammography (CEM) can safely reduce the number of breast biopsies for women with low-suspicion findings. About 2,100 women scheduled for biopsy will first get a CEM scan. If CEM shows the abnormality is likely benign, the biopsy may be avoided. The goal is to cut unnecessary biopsies by at least 20% while still catching nearly all cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Magee-Womens Hospital
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.